Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001810778 | SCV002048274 | uncertain significance | not provided | 2021-06-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001810778 | SCV004269122 | benign | not provided | 2023-10-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV005278890 | SCV005941089 | uncertain significance | not specified | 2024-12-23 | criteria provided, single submitter | clinical testing | The c.5915C>A (p.T1972N) alteration is located in exon 43 (coding exon 43) of the SPTA1 gene. This alteration results from a C to A substitution at nucleotide position 5915, causing the threonine (T) at amino acid position 1972 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |